XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.65

-1.0%

Jan 23 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (10789)	7/14/1999 7:44:00 PM
From: Robert K.	Read Replies (1) of 17367

Cacaito, from my previous post"The theory from the baboons study (which still may be incorrect)( I still have doubts), is that bpi is beneficial for its antibacterial effects (primarily) and NOT for its anti-endotoxin actions" That exactly my point, they claim antibacterial, but who knows. As you say>"I agree the main activity is to kill bacteria, but the second property is the one I am investing in Xoma, downregulation of the inflammatory chain." I am glad you see that too. BTW-I was hoping you would comment on the post cause I value your opinions greatly, and I know if I slip up you will be right there :-) And agreed, nothing quite like bpi. IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next